When studying how HIV-1 Nef can promote packaging of the proinflammatory transmembrane protease TACE (tumor necrosis factor-α converting enzyme) into extracellular vesicles (EVs) we have revealed a novel tyrosine kinase-regulated unconventional protein secretion (UPS) pathway for TACE. When TACE was expressed without its trafficking cofactor iRhom allosteric Hck activation by Nef triggered translocation of TACE into EVs. This process was insensitive to blocking of classical secretion by inhibiting endoplasmic reticulum (ER) to Golgi transport, and involved a distinct form of TACE devoid of normal glycosylation and incompletely processed for prodomain removal. Like most other examples of UPS this process was Golgi reassembly stacking protein (GRASP)-dependent but was not associated with ER stress. These data indicate that Hck-activated UPS provides an alternative pathway for TACE secretion that can bypass iRhomdependent ER to Golgi transfer, and suggest that tyrosine phosphorylation might have a more general role in regulating UPS.
It is likely that EVs also serve as pathogenic mediators in many different types of disease. 3, 4 EVs containing inflammation promoting factors can be found in the blood of HIV-infected individuals, and correlate with disease progression and poor recovery of the immune system following antiviral therapy. 5 A prominent component of circulating EVs collected from HIV-infected individuals is tumor necrosis factor-α converting enzyme (TACE), also known as a disintegrin and metalloproteinase 17 (ADAM17). 6, 7 Uploading of TACE into EVs is promoted by the HIV-1 pathogenicity factor Nef via its interactions with cellular protein kinases. 8 In addition to its role in TNF release, TACE is responsible for proteolytic maturation of other cytokines, cytokine receptors, and extracellular matrix components involved in inflammation. 6, 7 Thus, EV-associated TACE could be a key player in the chronic immune activation that drives AIDS pathogenesis and persistent viral replication.
EVs have also been implicated in stimulated secretion of interleukin-1β (IL-1β), a potent proinflammatory cytokine 9 produced upon inflammasome activation by bacterial and viral infections, or endogenous danger signals like ATP and urate. 10 IL-1β lacks a signal sequence for targeting it to the conventional endoplasmic reticulum (ER)-Golgi secretion route, and instead represents a prominent example of a protein released via unconventional protein secretion (UPS).
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Several different types of UPS pathways exist and can be utilized as an alternative Golgi-bypass secretion mechanism also by proteins having a canonical signal sequence. [12] [13] [14] A well-characterized example of this is the disease-causing variant ΔF508-CFTR of cystic fibrosis transmembrane conductance regulator, which is functional as an ion channel, but is defective in its trafficking to the plasma membrane. 15 Recently, Gee et al showed that surface expression and thereby function of ΔF508-CFTR could be rescued in vitro as well as in a mouse model of cystic fibrosis by directing an immature core-glycosylated form of ΔF508-CFTR to the plasma membrane via an unconventional
Golgi reassembly stacking protein (GRASP)-dependent secretion route. 16 The Golgi reassembly stacking proteins GRASP55 and GRASP65
were originally identified as factors required for the stacking and integrity of Golgi cisternae. 17 However, GRASPs are largely dispensable for the conventional anterograde protein transport, 18, 19 but instead have recently emerged as key factors in UPS that bypasses the Golgi. 20, 21 In this study we have examined the role of Src family kinases in regulating uploading of TACE into EVs, which led us to identify a tyrosine phosphorylation-regulated and GRASP-dependent unconventional secretion pathway that enables vesicle secretion of TACE independently of its otherwise essential ER-Golgi trafficking cofactor iRhom2. 23 was also co-transfected and detected with regular or phospho-Y31-specific antibodies.
As shown in Figure 1A , TACE was found in EV preparations from supernatants of all SFK-transfected cells, but not from cells transfected with TACE in the absence of a SFK (correlating with the lack of paxillin Y31 phosphorylation). Thus, at least in a tyrosine kinase overexpression model, triggering EV secretion of TACE is a property shared by different SFK members, and does not require ectopic expression of additional cellular or viral signaling factors.
Among the SFK family Hck is potently and preferentially activated by HIV-1 Nef. 24, 25 To generate a cell line model for studying TACE EV FIGURE 1 SFK activation induces TACE secretion into EVs. (A) HEK293 cells were transiently transfected with TACE, paxillin, dominantly active Hck, Lyn, Lck, Fyn or Fgr. Lysates of the transfected cells (Cell) and EV preparations (EV) isolated from their culture supernatants were subjected to WB using the indicated antibodies. The TACE antibody used was against the C-terminal tail. The SFKs were fusion proteins containing a biotin acceptor domain and were detected using labeled streptavidin. 
| Hck isoforms differ in their capacity to induce EV secretion of TACE
In addition to the myristoylated and palmitoylated p59Hck an alternative p61Hck isoform exists, whose translation starts at a CTG codon upstream of the p59 ATG start site. p61Hck is also myristoylated but lacks the palmitoylation signal. These differing acylation signals have been shown to direct p59 and p61 preferentially to the plasma membrane and lysosomes, respectively. 26 We compared the capacity of the p59 and p61 isoforms to activate secretion of TACE into EVs. As shown in Figure 1C , Figure 2A ). The apparent molecular weight of TACE can vary depending on its glycosylation status 27 and whether it has undergone proteolytic activation by furin-mediated removal of the N-terminal prodomain. 28 ,29 Therefore, we tested antibodies against the C-terminus or the N-terminus (prodomain) of TACE, and studied the effect of enzymatic deglycosylation on these TACE protein species. The 130 kDa species ("Band A") that was found only in the cell lysates, as well as the 105 kDa species ("Band B") that was present in the lysates and in the EVs could be detected either with an antibody targeting the TACE C-terminus or an antibody against the N-terminal prodomain, indicating that they had not been subjected to proteolytic activation. By contrast, the 80 kDa band ("Band C") that was found only in the EVs could not be detected with the anti-prodomain antibody, indicating that it represented a mature form of TACE lacking the autoinhibitory prodomain.
When the cell lysates were treated with the glycosidases Peptide-N-Glycosidase F (PNGase F) or Endoglycosidase H (Endo H), the 130 kDa band disappeared, whereas the intensity of the 105 kDa species increased, indicating that bands A and B represented differentially glycosylated forms of the same polypeptide, that is, prodomaincontaining full-length TACE. By contrast, deglycosidase treatment had no effect on the mobility of the 105 and 80 kDa TACE bands detected in the EVs, indicating that they represented hypoglycosylated forms of TACE with and without the prodomain, respectively. Both PNGase F and Endo H can remove high mannose glycan modifications introduced in the ER, but following their further modification in the Golgi they become resistant to Endo H and can be cleaved only by PNGase F. 30 Whereas no mature TACE (lacking the prodomain) was seen in untreated cell lysates, a faint signal for the 80 kDa band ("Band C") could be detected after treatment with PNGase F (but not with Endo H). This indicated that a small amount proteolytically activated TACE was also present in the cells, but was not evident in the untreated lysates because it was glycosylated and therefore comigrated with prodomain-containing, hypoglycosylated TACE species (Band B). Thus, the prodomain-containing 130 kDa TACE species in cell lysates was glycosylated only in an ER-specific manner, whereas the scarcely present prodomain-lacking form of TACE ("Band B*" as illustrated in Figure 2D ) had undergone further glycosylation in the Golgi.
However, the most important finding of these experiments was that neither PNGase F nor Endo H treatment changed the mobility of the prodomain-containing 105 kDa species or the proteolytically matured 80 kDa species of TACE in the EVs, thus showing that TACE secreted into EVs is hypoglycosylated.
To confirm that the 80 kDa TACE species in the EVs was indeed a product of prodomain cleavage at the furin target site we created a mutant form of TACE (TACE-FM) in which this furin cleavage site was disrupted by a KR 214 to NG substitution. 28 Confirming our assumption, when EVs from cells expressing TACE-FM were purified and analyzed the mature 80 kDa isoform (Band C) was absent and only the 105 kDa precursor form of TACE (Band B) could be detected ( Figure 2B ).
To study if the protease activity of TACE itself was relevant for EV secretion we also generated an inactive TACE mutant (TACE-CD) carrying a previously described E406A substitution 31 that disrupts its catalytic site. No difference in Hck-induced EV secretion was observed between this mutant and wild-type TACE ( Figure 2B ).
| Vesicle secretion of TACE is not mediated by iRhom2
The catalytically inactive members of the rhomboid family of proteases, iRhom1 and iRhom2, have been established as essential regulators of TACE maturation 27,32,33 required for ER-Golgi trafficking and subsequent cleavage of the prodomain of TACE. More recently, it was shown that iRhom2 regulates TACE throughout its lifecycle, and remains stably associated with TACE all the way through the secretory pathway. 34 Thus, overexpression of TACE alone in transfected HEK293 cells could be expected to result in a relative iRhom deficiency and a failure of the majority of cellular TACE to traffic and mature normally.
To further substantiate the idea that Hck-activated EV export of TACE was not iRhom-regulated we examined the effects of RNAimediated knock-down of iRhom2 expression as well as overexpression of iRhom2 together with TACE. We found that despite a potent suppression of iRhom2 expression in shRNA-transduced cells compared to the parental HEK293 cells, secretion of TACE into EVs was equally robustly activated by Hck in both cells ( Figure 3A ).
To overexpress iRhom2 we co-transfected the HEK293 cell with a vector for iRhom2-eGFP. Of note, this vector has been previously shown to encode a functional iRhom2 protein, 35 and it is known that addition of multiple epitopes tags at the C-terminus of iRhom2 does not affect its function as a transport/maturation cofactor and regulator of TACE. 34 Co-transfection of the iRhom2-GFP vector led to robust iRhom2
overexpression, but instead of promoting export of TACE into EVs, this resulted in a striking loss of TACE from the EVs ( Figure 3B ). Overexpression of iRhom2 caused no apparent change in the proteolytic maturation or glycosylation pattern (ie, electrophoretic mobility) of TACE, suggesting that proper trafficking of TACE through the trans Golgi network (TGN) might require additional cofactors whose expression in HEK293 cells become limiting in this setting.
In any case, we conclude that tyrosine phosphorylation-regulated uploading of TACE into vesicles is active when TACE is transfected alone, whereas co-expression of iRhom2 directed TACE to a different 
| EV secretion of TACE is independent of anterograde transport from the ER to the Golgi
The hypoglycosylated status of TACE uploaded into the EVs, and the independence of this process from the TACE trafficking cofactor iRhom suggested involvement of an unconventional secretion pathway. To test this idea, we treated the cells with brefeldin A (BFA), an inhibitor of the guanine nucleotide exchange factor GBF1 36 that has been widely used to inhibit protein transport from ER to Golgi.
We found that BFA treatment failed to prevent EV secretion of TACE triggered by Nef-mediated Hck activation in stably Hckexpressing cells ( Figure 4A ), although it efficiently inhibited trafficking of the multivesicular body (MVB)-derived exosome marker LAMP-1 into vesicles ( Figure 4B ). Of note, EV secretion of LAMP-1 was constitutive, and not positively or negatively regulated by Hck activation.
To ensure that the failure of BFA to block export of TACE into EVs was not due to an incomplete pharmacological effect; we also tested with a 10-fold higher concentration (2 μg/mL) of BFA and obtained identical results (Supporting information Figure S1A ). In addition, we verified the continued effectiveness of 200 ng/mL BFA treatment during the entire EV harvesting period by using confocal fluorescent microscopy to confirm a complete absence of normal Golgi morphology in these cells ( Figure S1B ).
Secretion of LAMP-1 into EVs was also blocked by tunicamycin (an inhibitor of N-glycosylation) and significantly reduced by thapsigargin (an inhibitor of sarco/ER Ca 2+ -ATPase), two agents that disturb ER function and induce ER stress 37 ( Figure 4B ). By contrast, Hckactivated EV secretion of TACE was not affected by treatment of the cells with tunicamycin or thapsigargin ( Figure 4A ). Thus, we conclude that secretion of TACE into EVs is mediated by an unconventional pathway that is not affected by ER dysfunction and does not involve anterograde vesicular transport of proteins from ER to Golgi, a key step in canonical protein secretion.
Of note, whereas blocking of conventional ER to Golgi-mediated secretion did not abolish vesicle secretion of TACE, it resulted in a specific disappearance of the proteolytically matured 80 kDa TACE species from the EVs ( Figure 4A ). This indicates that in order for unconventionally secreted TACE to be activated by prodomain removal, it must meet at some point along its way with furin or a furin-like protease that is trafficked via the conventional secretion pathway.
| Inducible EV secretion of TACE is not mediated by ER stress
A feature shared by many different types of UPS is that these pathways are activated by ER stress. 13 Therefore, whereas ER malfunction/stress did not prevent tyrosine kinase-activated EV secretion of TACE, it is also important to note that in the absence of Hck activation (when TACE was transfected without Nef ) BFA, tunicamycin or thapsigargin treatment alone did not induce secretion of TACE into vesicles without Hck activation ( Figure 4A ).
To confirm that treatment with these compounds did indeed induce ER stress we monitored changes in XBP1 mRNA splicing in these cells. As shown in Figure 4C , BFA and thapsigargin activated XBP1 mRNA splicing, an established outcome and reporter of ER stress. 37 By contrast, co-transfection of TACE together with Hck did not result in a change in XBP1 mRNA splicing. Thus, we conclude that induction of ER stress does not trigger unconventional secretion of TACE, and conversely, tyrosine phosphorylation-induced EV secretion of TACE was not associated with ER stress.
| Hck-induced EV secretion of TACE is GRASP55-dependent
Many UPS pathways have been found to involve the GRASP-family proteins. 21 We therefore used the CRISPR/Cas9 technology to knock out GRASP55 expression in HEK293 cells. In contrast to control cells the GRASP55-KO cells failed to secrete TACE into EVs were carried out to examine the role of GRASP65, only a very modest or no reduction in Hck-activated EV export of TACE was observed ( Figure 5B ).
In addition, we found that overexpression of GRASP55 but not GRASP65 could efficiently trigger EV secretion of TACE also in the absence of Hck activation ( Figure 5C ). Thus, while the mechanistic role of GRASP proteins in this process remains to be further elucidated, we conclude that similar to previously reported other unconventional secretion pathways, 21 tyrosine kinase-activated secretion of TACE into extracellular vesicles requires GRASP55.
| TACE-containing EVs are produced by an nSmase2-dependent exosome pathway
The two principal classes of EVs are named exosomes and ectosomes.
Exosomes are derived from intraluminal vesicles of multivesicular endosomes (MVE) following fusion of the MVE with the plasma membrane, whereas ectosomes are shedding vesicles that assemble and bud at the plasma membrane. 38 Ceramide is involved in MVE formation, and as originally reported by Trajkovic et al 39 , blocking of ceramide synthesis by inhibition of neutral sphingomyelinase-2 (nSmase2) has been widely used to interfere with exosome production. By contrast, nSmase2 inhibition does not prevent and can instead enhance the production of ectosomes. 40 In order to characterize the origin of the EVs involved in Hck-activated vesicle secretion of TACE we generated knock-down derivatives of HEK293 cells in which nSmase2 expression had been suppressed by lentivirally delivered shRNAs. We found that similar to the spontaneous EV secretion of LAMP-1, Hck-activated packaging of TACE into EVs was almost completely blocked as a consequence of the Smase2 knock-down ( Figure 6 ). By contrast, the EV association of HIV-1 Nef, a myristoylated membrane-targeted protein, was not at all affected by nSmase2 knock-down, suggesting that it was mainly associated with ectosomes.
Thus, we conclude that Hck-activates packaging of TACE into exosome-like vesicles that are derived from intraluminal vesicles of MVE rather than by budding directly from the plasma membrane.
| DISCUSSION
Signal peptide-containing proteins are traditionally thought to reach their final destinations by trafficking via the classical ER to Golgi early secretory pathway. 41 However, secretion of transmembrane proteins via a Golgi-bypass mechanism has also been described, which together with pathways for secretion of cytoplasmic proteins is known as UPS. [12] [13] [14] 42 Our interest in understanding how HIV-1 Nef can stimulate packaging of the immune regulator TACE into EVs has now revealed a novel tyrosine kinase-regulated UPS mechanism for TACE secretion.
Characteristic of UPS, Hck-triggered delivery of TACE into EVs could not be blocked by BFA, whereas this inhibitor of ER to Golgi transport effectively blocked incorporation of LAMP-1 into EVs. Also, compared to the cellular pool of TACE EV-resident TACE was distinctly hypoglycosylated, and did not change its electrophoretic mobility by a deglycosidase treatment.
Normal trafficking and proteolytic maturation of TACE depend on iRhom1/2, catalytically inactive members of the rhomboid-like superfamily that serve as chaperones or regulatory subunits controlling ER FIGURE 4 Hck-induced TACE secretion into EVs involves GRASP55 (A and B) TACE and/or Hck-p59 were transfected into wild-type, GRASP55 knock-out or GRASP65 knock-out HEK293 cells as indicated. Lysates of these cells were analyzed by WB for the expression of endogenous GRASP55 and GRASP65 and for transfected TACE and Hck proteins. EVs secreted by these cells were examined for their TACE content. (C) TACE was transfected into HEK293 alone (−) or together with Myc-tagged GRASP55 or GRASP65. Lysates of these cells were analyzed for the expression of the transfected TACE, Hck, and GRASP65/55 proteins, and the EV preparations from these cultures were probed with antibodies against TACE and tubulin. Quantification of the relative intensities of the specific protein signals are indicated under the blots to Golgi transport as well as subsequent fate of TACE. 34, 43 Thus, tyrosine phosphorylation-regulated UPS can provide an alternative, iRhom-independent secretion route for TACE. It is also interesting to note that previous examples of transmembrane proteins identified as clients of UPS are similarly restricted in moving from ER to Golgi because of the lack of a relevant binding partner or a mutation that interferes with folding. Specifically, under certain conditions Drosophila α-integrins are secreted via a Golgi-bypass mechanism without heterodimerization with a β subunit. 44, 45 On the other hand, the most common cystic fibrosis-causing mutation ΔF508-CFTR results in ER accumulation because of impaired folding, 15 which can be circumvented by activating trafficking to the plasma membrane via UPS. 16 Similarly, the predominant H723R mutation of pendrin (causing hearing loss and Pendred syndrome) leads to defects in folding and cellsurface expression of pendrin, which can be rescued by HSP70
co-chaperone DNAJC14-dependent UPS. 46 It should be noted, however, that certain transmembrane proteins may also use UPS as their regular mode of trafficking route. 12, 47, 48 While overall UPS-mediated trafficking of hypoglycosylated TACE into EVs was not prevented by BFA treatment, such inhibition of ER to Golgi transfer caused a specific loss of proteolytically matured TACE species from the EVs. Removal of the TACE prodomain is catalyzed by the proprotein convertase furin, 28, 29 which is acting in the TGN and subsequent endosomal compartments. 49 Thus, in order for the prodomain cleavage to occur the Golgi-bypass UPS pathway utilized by TACE must converge with trafficking of furin in a post-Golgi MVB-like endosomal compartment where the EVs containing proteolytically matured but hypoglycosylated TACE originate from. It would be interesting to examine whether this compartment is related to the syntaxin 13-containing endosomes involved in unconventional plasma membrane trafficking of CFTR described by Yoo et al. 50 Regardless of the identity of this vesicular compartment, the fact that furin can recognize and remove the prodomain of the hypoglycosylated TACE suggests that it has been properly folded. This is in agreement with the work of Adrain et al who found that inactive TACE immunopurified from cells lacking iRhom could be converted to a fully active TNF-processing enzyme by removal of its prodomain with recombinant furin. 27 Similar to most 21 but not all 51 UPS pathways tyrosine kinase triggered EV secretion of TACE was found to be GRASP-dependent.
TACE secretion was not observed in cells where GRASP55 was inactivated, and interestingly, could also be elicited in the absence of tyrosine kinase activation by forced GRASP55 overexpression. However, in contrast to most reported forms of UPS, including Golgi-bypass secretion of ΔF508-CFTR UPS, 16 tyrosine phosphorylation-regulated routing of TACE from ER into EVs was not triggered by ER stress. 
| Isolation of EVs
Forty-eight hours post-transfection, 12 mL supernatants were collected and centrifuged for 10 minutes at 1000g, 30 minutes at 10 000g and ultra-centrifuged for 90 minutes at 100 000g. Pellets were resuspended in 100 μL ×1 SDS PAGE sample buffer as EV preparations. For N-glycosylation study, EV pellets were resuspended in 10 mL PBS and ultra-centrifuged again at 100 000g for 90 minutes, and solubilized in 30 μL lysis buffer for further de-glycosylation analysis.
| XBP1 splicing
Total cellular RNA was isolated using the RNeasy Mini kit (Qiagen), including DNase digestion (RNase free DNase kit, Qiagen). Total RNA of 500 ng was transcribed to cDNA using the TaqMan reverse transcriptase kit (Applied Biosystems). Subsequently, 1 μL of diluted cDNA template (20 ng) was mixed with 200 μM of each dNTP, 300 nM forward (5 0 -TTA CGA GAG AAA ACT CAT GGC C-3 0 ) and reverse (5 0 -GGG TCC AAG TTG TCC AGA ATG C-3 0 ) primers, 5 μL ×10 optimized DyNAzyme buffer (F-511, Thermo), 1 μL DyNAzyme II DNA polymerase (Thermo) and nuclease-free water to a total volume of 50 μL. The PCR cycle starts with a 1 minute incubation at 94 C, then 35 cycles for 1 minute at 94 C, 1 minute at 54 C, and 1 minute at 72 C; this is followed by a final incubation at 72 C for 10 minutes. PCR products were separated by electrophoresis on a 3% agarose gel and visualized by Midori Green Advance DNA staining (Nippon Genetics Europe).
| Immunoblots
SDS gel electrophoresis and WB were carried out following standard procedures and using IRDye-labeled detection reagents. The blots were visualized and the signals quantified using the Odyssey infrared imaging system and Image Studio v3.1. software (LI-COR Biosciences).
All protein blotting results shown are representative of at least three comparable independent experiments.
| Microscopy
Cells were plated on 13 mm #1. 
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